Effect of 20 (S)-Protopanaxadiol on SMMC-7721 human liver cancer in vivo and in vitro

Chinese Pharmacological Bulletin

Volumn 24, Issue 11, 2008, Pages 1504-1508

  Zhang, Rui ^a   Xu, Hua Li ^a   Yu, Xiao Feng ^a   Qu, Shao Chun ^a   Chen, Ming Xia ^a   Sui, Da Yuan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

20 (S) Protopanaxasdiol; Apoptosis; Caspase 3; Liver cancer; Nude mice

Indexed keywords

CASPASE 3; PROTOPANAXADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MALE; MOUSE; NONHUMAN; RECEPTOR UPREGULATION;

EID: 60749127655     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fang T L, Lu M Q, Cai C J, et al. Quantified analysis of small interfering RNA silences transient expression of reporter gene in human hepatocarcinoma cells[J]. Chin Pharmacol Bull, 2007,23(8): 997-1001.
2. Kollmannsberger C, Mayer F, Kuczyk M, et al. Treatment of patients with metastatic germ cell tumors replasing after high-dose chemotherapy[J]. World J Urol, 2001,19(19):120-5.
3. Chester J D, Hall G D, Forster M, et al. Systemic chemotherapy for patients with bladder cancer-current controversies and future directions[J]. Can Treat Rev, 2005,30(4):343-58.
4. Ryba L P, Whitworth C A. Ototoxicity: therapeutic opportunities [J]. Drug Discov Today, 2005,10(19):1313-21.
5. Tang Y, Li X H. Inhibitory effects of Zedoray Rhizome abstracts on hepatic cell line HepG2 and their mechanisms[J]. Chin Pharmacol Bull, 2007,23(6):790-4.
6. Zhang H L, Zhang M Y, Zhou A Q. The Effect of Inhibition of Growth Induced by PachLaxel in Cervical Cancer HeLa Cefts[J]. J Basic Clin Oncol, 2006,19(4):291-3.
7. Jing S Z, Ling Y H, Nicole B, et al. Oral RDP58 allow CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity[J]. Clin Can Res, 2004,10(8):2851-9.
8. Sawhney R, Bourgeois D, Chaudhary UB. Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead[J]. Ann Oncol, 2006,17(9):1360-9.
9. Takahide O, Masayo M, Shizuo O, et al. Mechanism of action of ginsenoside Rb3: uptake and Metabolism of ginsenoside Rb3 by cultured B16melanoma cells[J]. J Pharm Sci, 1991, 80 (12): 1141-6.
10. Li X W, Lin Y F, Zheng Y, et al. Determination of 20 (S)-proto-panaxadiol in acid and alkaline degradation products for saponins from leaves of Panax qinquefolium. L. by RP-HPLC[J]. J Jilin Univ(Med Ed), 2006,32(2):353-6.
11. Xie J T, Wang C Z, Wang A B, et al. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng[J]. Acta Pharmacol Sin, 2005,26(9):1104-10.
12. Liu C Y, Gu Z L, Du C M, et al. Effect of flavonoids of Astragalus complanatus on SMMC7721 human liver caner subcutaneous transplanting tumor in nude mice[J]. Chin Pharmacol Bull, 2007,23 (6):781-4.
13. Fan C L, Luan Y, Chen Y, et al. Effects of chlorzoxazone on HepG2 tumor cells[J]. Chin Pharmacol Bull, 2007,23(9):1198-202.
14. Ashkenazi A. Targeting death and decoy receptors of the tumor-necrosis factor superfamily[J]. Nat Rev Can, 2002,2(6):420-30.
15. Zhang Y L, Yang Y D, Li Z Q, et al. Antitumor activity of santamarin and its effect on topoisomerase[J]. Chin Pharmacol Bull, 2007,23(10):1370-4.